TY - JOUR
T1 - Analysis of 45 episodes of arterial occlusive disease in Japanese patients with congenital protein C deficiency
AU - Sakata, Toshiyuki
AU - Kario, Kazuomi
AU - Katayama, Yoshiaki
AU - Matsuyama, Tatsuo
AU - Kato, Hisao
AU - Miyata, Toshiyuki
N1 - Funding Information:
This study has been supported in part by a Grant-in-Aid for Special Coordination Funds for Promoting Science and Technology (Encouragement System of COE), the Science and Technology Agency of Japan, and the Kato Memorial Bioscience Foundation.
PY - 1999/4/15
Y1 - 1999/4/15
N2 - Hereditary protein C deficiency is associated with a predisposition to venous thrombosis. It is not clear whether the deficiency is involved in arterial occlusion. In the present study, we screened for protein C amidolytic activity in patients admitted to the National Cardiovascular Center Hospital, and we identified among them 43 probands and 51 relatives with heterozygous protein C deficiency. Among them, 34 patients with heterozygous protein C deficiency had manifested 45 episodes of arterial occlusive disease. Venous thrombotic diseases were less common. In the examination of whether protein C deficiency hastens arterial occlusion, we found a significant difference (p=0.02) in the age at onset of acute myocardial infarction between the patients with protein C deficiency (n=10; 49.4±14.8 years) and a group of patients with normal protein C levels (n=42; 60.5±10.6 years). Acute myocardial infarction occurred before 40 years of age in a significantly greater proportion of the patients with protein C deficiency (3:10, 30%) as compared with the controls (2:42, 5%) (χ2=5.9, p=0.015). At the onset of atherothrombotic cerebral infarction the patients with protein C deficiency were significantly (p=0.022) younger (n=11; 57.4±12.8 years) than those with normal protein C levels (n=48; 64.6±10.1 years). Venous thrombosis was the most frequent clinical manifestation (21 of 31 episodes) in the patients with antithrombin III deficiency (n=26; 68% of the total), who were admitted to our hospital. Thus, our study suggests that congenital protein C deficiency contributes to earlier onset of arterial occlusive diseases, especially acute myocardial infarction, in Japanese subjects.
AB - Hereditary protein C deficiency is associated with a predisposition to venous thrombosis. It is not clear whether the deficiency is involved in arterial occlusion. In the present study, we screened for protein C amidolytic activity in patients admitted to the National Cardiovascular Center Hospital, and we identified among them 43 probands and 51 relatives with heterozygous protein C deficiency. Among them, 34 patients with heterozygous protein C deficiency had manifested 45 episodes of arterial occlusive disease. Venous thrombotic diseases were less common. In the examination of whether protein C deficiency hastens arterial occlusion, we found a significant difference (p=0.02) in the age at onset of acute myocardial infarction between the patients with protein C deficiency (n=10; 49.4±14.8 years) and a group of patients with normal protein C levels (n=42; 60.5±10.6 years). Acute myocardial infarction occurred before 40 years of age in a significantly greater proportion of the patients with protein C deficiency (3:10, 30%) as compared with the controls (2:42, 5%) (χ2=5.9, p=0.015). At the onset of atherothrombotic cerebral infarction the patients with protein C deficiency were significantly (p=0.022) younger (n=11; 57.4±12.8 years) than those with normal protein C levels (n=48; 64.6±10.1 years). Venous thrombosis was the most frequent clinical manifestation (21 of 31 episodes) in the patients with antithrombin III deficiency (n=26; 68% of the total), who were admitted to our hospital. Thus, our study suggests that congenital protein C deficiency contributes to earlier onset of arterial occlusive diseases, especially acute myocardial infarction, in Japanese subjects.
KW - Acute myocardial infarction
KW - Arterial occlusion
KW - Atherothrombotic cerebral infarction
KW - Cerebral infarction
KW - Protein C deficiency
KW - Risk factor
UR - http://www.scopus.com/inward/record.url?scp=0033560660&partnerID=8YFLogxK
U2 - 10.1016/S0049-3848(98)00194-7
DO - 10.1016/S0049-3848(98)00194-7
M3 - Article
C2 - 10230891
AN - SCOPUS:0033560660
SN - 0049-3848
VL - 94
SP - 69
EP - 78
JO - Thrombosis Research
JF - Thrombosis Research
IS - 2
ER -